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2 Abstract 
 
Exosomes are nanoparticles being released by various types of cells and they often 
carry functional cargo, including RNA and proteins, and provide a means to shuttle 
these cargos between cells. Emerging evidence suggest that exosomes are vital 
player in process such as intercellular communication and indirect gene regulation 
through protein and non-coding RNA cargo. The ability of efficient and secure 
exosome-mediated molecules transfers leads to a novel avenue to understand 
immune response regulation towards diseases and cancers. Several research 
groups have proven that exosomes are involved in intercellular communication 
between dendritic cells, T cells and B cells. Nonetheless, B-to-B cell communication 
and regulation of adaptive immune response via exosomal pathway haven’t been 
well studied. In this thesis, we investigated the role of exosomes in B cell 
development and antibody class switching recombination (CSR), an important 
process in adaptive immune response where mature B cells respond to antigens and 
secret classes of antibodies in order to diversify antibodies’ effector function. We 
observed CSR impairment under the depletion of bovine exosomes in cell medium 
and endogenous exosomes derived from CH12, a murine B lymphoma cell line.. 
Interestingly, complement of exosomes from naïve CH12 appear to be suppressive 
for CSR whilst exosomes from activated CH12 show a facilitating effect. Preliminary 
investigation in exosomal RNA showed selective packaging of exosomal cargo 
during CSR and such findings could provide a more accurate direction in 
understanding exosome-mediated regulation in CSR. 
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4 Introduction 
 
Exosomes are cell-derived lipid nanoparticles that can be found in numerous biofluid 
sources, including blood, urine, tears, and breast milk. Exosomal particle dimensions 
range from 30 to 100 nm in diameter (1). The biogenesis of exosomes is widely 
believed to involve multiple cellular stages, inward budding of endosomal membrane 
that forms the multivesicular bodies (MVBs), transfer of MVBs to the plasma 
membrane, merge of MVBs with the plasma membrane and release of internal 
vesicles to the extracellular space (2). A vast majority of cell types, including cells 
grown in culture, generate and release exosomes, and emerging findings is showing 
that exosomes participate in number of biological processes including intercellular 
communication and antigen presentation in diverse aspects such as immune 
modulation and cancer proliferation (3). Studies have shown that most of the content 
of exosomes reflect their parental cell of origin. This useful feature allows exosomes 
to serve as the next generation biomarker for clinical diagnosis and therapy (4). Such 
intercellular communication is mainly facilitated by the active packaging of cargos, 
including DNA, RNA, proteins and lipids in a selective manner. The shuttling of the 
mixed cargos between cell of origin and targeted recipient cells is surprisingly 
efficient and reliable due to the apparent stability of exosomes in body fluids (5). For 
example, in vitro studies have shown that exosomal miRNA is able to downregulate 
known target genes in distant recipient cells (6). However, little is known about the 
network of biological processes exosomes involved and there are still many technical 
limitations which make them even more challenging to study. 
 
Detection and quantification of exosomes are still not very well established due to 
their small sizes and the technical difficulties associated with detecting them using 
either flow cytometry or conventional light microscopy. That is why, Transmission 
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electron microscopy (TEM) is currently still the golden standard of exosome 
detection but the whole process requires extensive sample preparation (7). 
Nanoparticle tracking analysis (NTA) has been widely used for detection and 
quantification of exosomes due to its shorter sample preparation time compared to 
TEM. Briefly, NTA measure the concentration and sizes of particles by relating the 
rate of Brownian motion to particle size but the accuracy of this approach can be 
affected by the instrument settings and calibration (8). Flow cytometry has been 
emerging as a robust and fast way to detect and quantify exosomes. Moreover, flow 
cytometry allows multiplex fluorescence detection which means molecular 
information is available alongside. These properties are especially useful for clinical 
applications such as diagnosis and prognosis (9). However, a dedicated set up is 
essential to provide accurate sizing of nanoparticles as the detection limit of 
conventional flow cytometers are around 500 nm. Also, dedicated set up requires a 
considerably powerful flow cytometer and lengthy process of trial and error for 
detection of exosomes coming from different cell origins. Here, we attempted to 
develop a flow cytometry-based method using B cell-specific antibody coated beads 
that are readily and accurately detectable by conventional flow cytometer. Using this 
method, we expected to quantify exosomes shredding from inactivated and activated 
B cells. 
 
It has been reported that CD8 T cell-mediated immune response is triggered and 
modulated by B cell-derived exosomes (10). Interestingly, recent studies have shown 
that B lymphoma cells utilize exosomal pathway(s) to evade humoral immunotherapy 
by releasing exosomes that carry their own surface antigen (Ag) CD20, binding to a 
highly utlilized therapeutic anti-CD20 antibodies called Rituximab, thereby 
neutralizing complement and shielding the cancer cells from antibody-based 
immune-therapy (11). This indicates the exosome is a courier platform shared 
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between normal and cancer immune cells for diverse vital purposes. 
 
Another unexpected aspect of exosomes is that it has a rather different profile of 
content compared to that of their parental cells, especially RNA. Generally, exosomal 
cargo mirrors the abundance and types of the parental cellular content based on the 
biogenesis of exosomes which involves inward budding of the endosomal 
membrane. However, several studies have discovered that specific RNAs are 
enriched in exosomes as compared to parental cells. For instance, a subset of 
miRNA with potential role in endocytosis regulation are enriched in 293T derived 
exosomes; MiR-451 is found persistently enriched in exosomes in many cell types 
such as breast cancer cells lines and mesenchymal stem cells (12). Such 
discrepancy in RNA abundance and types between exosomes and parental cells 
suggesting the packaging of exosomal cargo isn’t a passive process and the 
underlying selective loading mechanisms are under intensive investigation. 
 
In this study, we investigated the role of exosomes in B cell intercellular 
communication including B cell development and immunoglobulin class switching 
recombination (CSR). CSR is a unique process in adaptive immune response that 
allow B cells to produce different classes of antibodies after activation by T cell 
cytokines. During CSR, double-stranded breaks occur at the switch (S) regions of 
the antibody heavy chain locus at 2 selected sites facilitated by series of enzymes 
including Activation-Induced (Cytidine) Deaminase (AID). The DNA locus between 
the 2 selected sites on S regions are removed from the chromosome, namely μ and 
δ constant gene segments which encode for immunoglobulin (Ig) M and IgD 
respectively in inactivated naïve B cells. The removal of the selected S regions is 
followed by substitution of γ, α, ε constant genes which encode for IgG, IgA and IgE 
respectively. The 2 free DNA ends of S regions are then rejoined by non-homologous 
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end joining (NHEJ) and resulting in the expression of switched antibody class (13). 
 
The current understanding of CSR regulation is mainly based on antigen recognition, 
T cell binding, and cytokine induction which together culminate in the maturation of B 
cells and stimulation of AID mutagenic activity (13). Interestingly, miR-155, a 
common exosomal RNA cargo across many cell types, was shown to directly 
downregulate AID expression which can possibly lead to downregulation of CSR in B 
cells (14). This leaded to a new path for us to discover the possibility of CSR 
modulation at the post-transcriptional level via exosomal pathway, especially 
exosomal RNA. In this study, we use CH12, a murine B lymphoma cell line as a 
study model since they switch predominantly µ to α percentage (up to 50%) which 
gives robust and reliable result compared to primary B cells which able to switch to 
either IgG1 or IgG3 up to 30% and 10% respectively. Therefore, CH12 serves a 
better model in this study During CSR, around 30% of the CH12 population was 
activated and switched from IgM to IgA with IL-4/TGF-β/CD40-L stimulation and such 
isotype switching act as a checkpoint in B cell development. We identified exosome-
facilitated intercellular communication is an alternative pathway to regulate CSR. B 
cell endogenous exosomes formation was reduced with GW4869, inhibitor of 
neutral-sphingomylelinase (n-SMase) which has been shown to inhibit exosome 
release from cells (15). We found  decreased endogenous exosome production 
lead to a significant reduction of CSR efficiency. Surprisingly, the depletion of 
exogenous exosomes in culture medium also lead to significant reduction of CSR 
efficiency up to 50%. This indicated that both endogenous and exogenous exosomes 
might share common molecular packages that are responsible for CSR modulation. 
To validate the responsible role of exosomes in CSR modulation, we attempted to 
activate GW4869-treated CH12 to undergo CSR with the supplement of exosomes 
derived from bovine serum, inactivated CH12 and activated CH12 separately. 
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Interestingly, reduction of CSR efficiency caused by depletion of endogenous and 
exogenous exosomes, can be reconstituted by the addition of both bovine serum 
and activated CH12-derived exosomes but not the inactivated CH12-derived 
exosomes. 
 
It has been reported that the molecular components in exosomes are mostly small 
RNA and there are evidence showing that exosomal miRNA take part in intercellular 
gene expression regulation in a targeted manner (16). Furthermore, there are 
evidences showing both exogenous- and endogenous-derived non-coding RNAs can 
indirectly modulate CSR by mediating precise AID targeting (17). Another well-known 
characteristics of non-coding RNAs (ncRNA) is the ability to control gene expression 
at the post-transcriptional level via sequence specific interaction with the regulatory 
sites. In the context of exosomal cargo shuttling, exosomal ncRNAs not only 
affecting their host cells’ gene expression, they can also manipulate gene expression 
in neighbour cells as well as distant cells, possibly across different cell types or 
between lesion cells and normal cells. To understand whether B cells also exploit 
such a pathway to regulate CSR, i) we investigated the role that small and 
longncRNA play in both CH12 cells and their corresponding exosomal cargo. From 
this set of paired cell and exosomes samples, ii) we quantified expression 
differences in multiple RNA classes as well as essential genes required for CSR, 
namely AID (gene that encode activation-induced (cytidine) deaminases that initiate 
CSR via causing mismatch on Switch region), Sα (encoding for IgA), Sµ (encoding 
for IgM) and Sµ-lariat (intronic RNA lariat required for targeting of AID to Switch 
region via debranching of lariat) between cells and exosomes, pre- and post-
activation for CSR, to identify significant differentially expressed transcripts in cells 
versus exosomes and iii) to elucidate the underlying gene regulation network of CSR 
in the exosomal pathway. 
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5 Materials and methods 
 
5.1 Cell culture 
CH12 cells were grown at 37 °C and 5% CO2 in RPMI 1640 (GE Healthcare 
Hyclone) supplemented with 10% heat-inactivated fetal calf serum (Gibco, Life 
Technologies), 50 U/mL penicillin/streptomycin (Gibco, Life Technologies), 5% 
NCTC-109 medium (Gibco, Life Technologies), 2 mM L-glutamine (Gibco, Life 
Technologies), 1 mM sodium pyruvate (Gibco, Life Technologies), 50 µM 2-
mercaptoethanol (Gibco, Life Technologies). Primary B cells were grown at 37 °C 
and 5% CO2 in RPMI 1640 (GE Healthcare Hyclone) supplemented with 10% heat-
inactivated fetal calf serum (Gibco, Life Technologies), 50 U/mL 
penicillin/streptomycin (Gibco, Life Technologies), 2 mM L-glutamine (Gibco, Life 
Technologies), 1 mM sodium pyruvate (Gibco, Life Technologies), 50 µM 2-
mercaptoethanol (Gibco, Life Technologies) 
 
5.2 Endogenous exosome inhibition and CH12 CSR 
CH12 cells were pre-treated with GW4869 (10 mM Sigma Aldrich) for 2 hours and 
washed with 1 × PBS twice. Washed cells were grown in bovine exosome-depleted 
media supplemented with GW4869 and stimulated to undergo CSR. Bovine 
exosomes were depleted by overnight centrifugation at 120,000 × g. In short, CH12 
cells were stimulated with 20 ng/mL IL-4, 1 µg/mL monoclonal anti-CD40 and 1 
ng/mL TGF-β at 2 × 105 cells/mL and cells were collected 48 hours for downstream 
assays and exosome isolation. Splenic primary B cells were isolated from wild type 
C57BL/6 female mice (>6 weeks old) and stimulated to undergo CSR with 20 ng/ml 
IL-4, 2 µL/culture medium lipopolysaccharide (LPS) solution (500X) (eBioscience) at 
2 × 105 cells/mL and cells were collected every 24 hours for downstream assays and 
exosome isolation 
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5.3 Exosome isolation 
48 hours after cytokine stimulation, CH12 cells at 1 × 106 cells/mL were washed with 
sterile PBS twice and allowed to grow in bovine exosome-depleted media for 24 
hours reaching maximum density of 2 × 106 cells/mL. Bovine exosomes were 
depleted by overnight centrifugation at 120,000 × g. To collect CH12 exosomes, 
CH12 cells were pelleted at 300 × g for 5 minutes and saved for RNA collection and 
surface Ig detection by flow cytometry. The remaining medium was centrifuged at 
10,000 × g for 15 minutes and then subjected to ultracentrifugation at 110,00 × g for 
70 minutes to pellet exosomes (Type 42.1 rotor). Exosomes pellet were washed in 1 
× PBS and centrifuged again at 110,000 × g for 70 minutes (Type 42.1 rotor). All 
centrifugation was performed in 4 °C. 
 
5.4 Exosome characterization 
Exosomes isolated from CH12 were characterized by transmission electron 
microscopy and flow cytometry (BD Accuri C6 plus). For flow cytometry, ‘homemade’ 
antibody coated beads were used according to (17). Briefly, 3 µm latex beads 
(Sigma Aldrich) were incubated with anti-CD63 (Santa Cruz Biotechnology) overnight 
at room temperature. Purified CH12 exosomes were then incubated with the 
antibody coated beads overnight at 4 °C. Exosome-bead complexes were washed 
with wash buffer then incubated with FITC-anti-IgM (BD Pharmingen) in dark for 40 
minutes at 4 °C before data acquisition. 
 
5.5 Flow cytometry analysis of CH12 
CH12 cells were pelleted and washed in 1 × PBS twice and incubated with APC-anti-
IgM (1:200 BD Pharmingen) and FITC-anti-IgA (1:200 BD Pharmingen) in dark for 40 
minutes at 4 °C before data acquisition using flow cytometer (BD Accuri C6 plus). 
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Primary B cells were washed in 1 × PBS twice and incubated with APC-anti-IgG1 
(1:200 ebioscience) and FITC-anti-IgM (1:200 BD Pharmingen) in dark for 40 
minutes at 4 °C before data acquisition using flow cytometer (BD Accuri C6 plus). 
 
5.6 RNA extraction using TRI reagent and tapestation analysis 
1 mL of TRI reagent (Invitrogen) were used to lyse CH12 cell pellet and exosome 
pellet. 200 µL of chloroform was added to the homogenized mixture and centrifuged 
at 12,000 × g for 15 minutes at 4 °C. RNA in the aqueous phase was precipitated by 
adding 500 µL of isopropanol and centrifuged at 12,000 × g for 10 minutes at 4 °C. 
RNA pellet was washed with 75% ethanol and centrifuged at 7,500 × g for 5 minutes 
at 4 °C. RNA pellet was left to air dry briefly and dissolved in nuclease-free water. 
RNA quality and quantity were examined using an Agilent 2200 Tapestation 
bioanalyzer (Agilent Technologies, Santa Clara, CA). 5 µL of RNA sample buffer was 
mixed with 1 µL RNA sample. The sample mixture was heated at 72 °C for 3 minutes 
then placed on ice for 2 minutes. RNA samples were loaded to the 2200 Tapestation 
instrument for data acquisition. RNA quality and quantity were analyzed in the 2200 
Tapestation controller software, electropherogram and gel electrophoresis images 
were generated in the software. 
 
5.7 Real time quantitative polymerase chain reaction 
Eluted exosomal RNA were reverse transcribed to cDNA (ProtoScript® II First Strand 
cDNA Synthesis Kit) and qPCR was performed in triplicates using Brilliant II SYBR 
green (Agilent) and Rotor-Gene Q (Qiagen), transcripts quantities were normalized 
to β-actin. 
Primers: murine AID (F) CTCCTGCTCACTGGACTTCG, murine AID (R) 
AGGCTGAGGTTAGGGTTCCA. murine B-Actin(F) GGCTCCTAGCACCATGAAG, 
murine B-Actin(R) GAAAGGGTGTAAAACGCAGC, SµGLT(F) 
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CTCTGGCCCTGCTTATTGTTG, SµGLT(R) AATGGTGCTGGGCAGGAAGT, 
SαGLT(F) CCAGGCATGGTTGAGATAGAGATAG, SαGLT(R)
 GAGCTGGTGGGAGTGTCAGTG, Sµ lariat(F) 
AAGAGTAGCAACAAGGAAATAGCAG, Sµ lariat(R) 
GCAGAAACAGTTTACAAGCTTTAAGA (18) 
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6 Results 
 
6.1.1 Characterization of exosomes derived from CH12 by TEM 
Exosomes derived from CH12 were isolated by serial ultracentrifugation method (Fig 
1A). To validate the method, we investigated the sizes and the morphology of the 
purified exosomes. Transmission electron microscopy (TEM) was used to image 
exosome from pellets or from serum suspensions. The content was fairly 
homogenous particles with bilayer membrane of sizes around 50 nm in diameter 
(Figure 1B). The cup-shaped morphology and the average size of the purified CH12 
exosomes confirmed the typical feature of exosomal particles and exosomes derived 
from other types of B cells (19). 
 
6.1.2 Characterization of exosomes derived from CH12 by immuno-gold TEM 
after CSR 
Exosomes were shown to incorporated with antigens from their parental antigen-
presenting cells and able to modulate immune responses between dendritic cells 
and T cells through such characteristics (10) (20). In order to understand whether 
surface immunoglobulin (Ig) on B cells is being shuttled into the exosome pathway, 
we applied immunogold labelling to detect the presence of B cell specific Igs on 
primary- and CH12- derived exosomes on B cell surface. We successfully detected 
IgM on the surface of purified exosomes derived from inactivated CH12 (Fig. 1C) 
which agreed with previous characterization of B cell exosomes (19). Around 30% of 
the CH12 population’s surface Ig switches from IgM to IgA 48 hours during CSR. We 
tried to understand whether the amount of exosomal surface Ig released from 
switched cells could reflect their parental surface isotype. We applied immunogold 
labelling approach to characterize exosomes derived from inactivated and activated 
CH12. IgM were detected on the surface of both inactivated and activated CH12 
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exosomes, however, the density difference of IgM is not noticeable (Fig 1D). 
 
 
 
 
Fig.1 Detection and Quantification of EV isolated from supernatants of CH12, a murine B lymphoma 
cell line. A) Schematic outline of exosome purification by serial ultracentrifugation. B) TEM of isolated 
CH12 exosomes. Red arrows indicate isolated examples. Bar, 200 nm. C) Immuno-gold labelling 
(anti-IgM) of exosomes from unswitched CH12. Black dots indicate presence of IgM. D) Immuno-gold 
labelling (anti-IgM) of exosomes from activated CH12. Black dots indicate presence of IgM. 
 
 
6.1.3 Characterization of exosomes in primary B cells and CH12 by FACS 
Aside from TEM and immunogold labelling, flow cytometry is also adopted to 
characterize exosomes due to its ability for easy and fast high-throughput qualitative 
and quantitative analysis as well as providing comprehensive information such as 
particle counting and sizing which the TEM technology cannot match. Establishing a 
reliable and robust flow cytometry-based set-up specialized for exosome analysis is 
vital for its ongoing research not only because time and labour saving for obtaining 
equal amount of information, also allows researchers to enhance their understanding 
in more complex exosomes-mediated pathways by providing them multi-dimension 
17 
 
data. However, limitations such as heterogeneity, low refractive index and small size 
make the application of conventional flow cytometry to analysis exosomes become 
not reliable and accurate. Therefore, we attempted to optimize a flow cytometry-
based method to characterize B cell exosomes. 
 
Preliminary experiment was performed where serially ultracentrifuged purified CH12 
exosomes were labelled with APC-conjugated IgM and FITC-conjugated IgA and 
examined by flow cytometry directly. Over 70% of the population expressed neither 
IgM nor IgA, 23% were IgM positive and less than 4% were IgA positive (Fig. 2A). 
However, under our flow cytometer configuration, purified exosomes were likely 
indistinguishable from antibody aggregates based on size or refractive properties 
(Fig. 2B). In other words, surface Ig profile generated is likely a false positive or false 
negative result due to the confusion of target population. We therefore need extra 
analysis to test whether our flow cytometer is capable of resolving particle size 
differences in the nanoparticle range. To do so, we employed latex beads with known 
sizes; namely 100 nm, 500 nm and 1 µm as size controls in order to confirm the 
resolution power of the flow cytometer. However, there was only one population of 
particles observed based on sizes instead of 3 distinct populations of particles as 
expected (Fig. 2C). This means our flow cytometer doesn’t have enough resolution 
power to discriminate exosomes and immunofluorescent antibodies aggregates used 
in this assay based on their sizes. 
 
Since the sizes of nanoparticles weren’t a suitable parameter to accurately analyse 
exosomes using flow cytometry, we attempted to fluorescently label exosomes via 
staining the parental cells with protein dye (CellTrace Far Red Cell Proliferation Kit) 
and the stained proteins should be packaged into exosomes that eventually gets 
released into the exosomal cargo (Fig. 2D). Subsequently, the exosome population 
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can be distinguished from antibodies aggregates based on the expected differential 
fluorescence emission rather than size difference. CSR efficiency of CellTrace 
labelled CH12was validated in order to confirm the core process of the study, B cell 
CSR, wasn’t disturbed by the CellTrace protein dye (Fig. 2E & 2F). Next, exosomes 
released from CellTrace labelled CH12, with and without stimulation for CSR, were 
collected after 48 hours, labelled with FITC-IgA and analysed by flow cytometry. 
CellTrace fluorescent signals from negative controls including PBS, cell culture 
media and cell culture media with FITC-IgA were used to determine the threshold for 
positive and negative CellTrace population (Fig. 2G). CellTrace positive population of 
each sample were gated and the corresponding IgA profile was analysed. However, 
we could not detect any distinct separation of IgA positive or negative peaks 
generated from the gated population and we couldn’t confidently determine the 
profile of exosomal surface Ig by this approach (Fig. 2H). 
 
Since the sizes of exosomes are below the detection limit of conventional flow 
cytometers which means it is unlikely to distinguish exosomes from cytometer 
background noise (Figure 2I), thus, exosomes have to first bind to larger antibodies 
coated beads in order to be detected. We coupled anti-IgM antibodies with 3 µm 
latex beads to produce antibodies coated beads. The beads were then incubated 
with purified exosomes derived from inactivated and activated CH12 for CSR to form 
the exosome-bead complexes. The complexes were immunofluorescent stained with 
anti-IgM and anti-IgA antibodies separately and data was acquired using flow 
cytometry. A distinct population of particles representing the exosome-bead 
complexes was identified and distinct from the background noise in the forward and 
side scatter plot (Figure 2J). The exosome-bead population was gated (Figure 2J) 
and surface Ig composition of both inactivated and activated CH12 exosomes is 
shown in (Figure 2K). However, possibly due to the low density of exosomal surface 
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Ig immunofluorescence to be detected by the cytometer, differences in IgM or IgA 
positive percentages from both populations were barely noticeable. 
 
 
 
Fig. 2 CellTrace labelling dependent and antibody coated beads dependent flow cytometry-based 
analysis of exosomes. A) Surface IgM/IgA profile of purified CH12 exosomes. B) Cytogram shows 
forward scatter versus side scatter, purified exosome population in blue and antibodies aggregates in 
red. C) Cytogram shows forward scatter versus side scatter, combination of different sizes of latex 
beads. D) Schematic outline of CellTrace labelling dependent exosomes analysis approach. E) Flow 
cytometry analysis showing the incorporation of CellTrace dye to CH12 cells, Day 0 in red, Day 2 
unswitched in blue, Day 2 switched in orange (n=3 per group). F) Flow cytometry analysis of 
CellTrace labelled CH12 cell CSR from IgM to IgA, ±activation after 48 hours, unswitched in blue, 
switched in orange (n=3 per group). G) Flow cytometry analysis of CellTrace labelled CH12 exosomes 
and controls (n=3 per group), line: Threshold for CellTrace positive and negative population. H) Flow 
cytometry analysis of CH12 exosomal surface IgA from CellTrace positive population. I) Flow 
cytometry-based detection of exosomes. Blue population represents purified exosomes; Red 
population originate from filtered PBS only, representing background noise. J) Flow cytometry-based 
detection of exosomes coupled with antibody-coated beads. Distinctive population of exosome-bead 
complexes shown in blue was gated and background noise in red. K) Flow cytometry analysis of 
surface Ig on CH12 exosomes. Blue population represents inactivated CH12 exosomes; Red 
population represents activated CH12 exosomes. 
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6.2.1 Validation of GW4869 inhibitory effect on exosome production 
Following our efforts to characterise exosomal particles we now shifted our attention 
to understand the biological functions of exosomes. To validate the inhibitiory effect 
of exosome production we used a widely used inhibitor known as GW4869. In brieft, 
GW4869 inhibits the enzymatic function of neutral sphingomyelinase (n-SMase) 
which hinders ceramide-mediated inward budding of MVBs and the release of 
exosomes from MVBs. Cell culture medium from GW4869- and mock- treated CH12 
was subjected to TEM imaging. Exosomes were still detectable from GW4869 
treated CH12 (Fig. 3A), however, with a significant reduction in density compared to 
mock treated CH12 (Fig. 3B). Since the GW4869 drug is dissolved in DMSO, which 
has inherent toxicity to cells, the dose used in this assay was previously determined 
by using the half maximal inhibitory concentration (IC50) (Figure 3C), whether such 
inhibitory effect of exosome production is dose dependent is yet to be confirmed. 
 
 
6.2.2 Exogenous and endogenous exosomes regulate CSR in CH12 
To gain insight into the role of exosomes in B cell development, specifically CSR, we 
activated CH12 to undergo CSR using the cytokine cocktail IL-4/TGF-β/CD40-L 
stimulation with the depletion of exogenous (originating from fetal calf serum, FCS) 
and endogenous (originating from the CH2 cells) exosomes. To deplete exogenous 
exosomes, FCS media was subjected to overnight ultracentrifugation (16) and the 
supernatant was recovered to use in our experimental cell culture media preparation. 
For the depletion of CH12 exosomes, CH12 was treated with GW4869, inhibitor of n-
SMase which is known to block ceramide production, ultimately reducing exosome 
shedding from cells into the culture media. 
 
Firstly, the depletion of FCS exosomes alone leaded to near 60% decrease in CSR 
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efficiency compared to control 48 hours after cytokine stimulation (Fig. 3D). This is 
suggestive that certain FCS exosomal cargo is essential for efficient CSR. Secondly, 
the depletion of CH12 exosomes alone has no significant effect in CSR efficiency 
compared to mock treatment (Fig. 3D). It is also suggestive that, with respect to 
CSR, CH12 exosomes are dispensable when FCS exosomes are present. 
Interestingly, depleting both FCS and CH12 exosomes by GW4869 lead to less than 
40% decrease in CSR efficiency compared to depletion of FCS exosomes with mock 
treatment (Fig. 3D). It is plausible then that CH12 exosomes are antagonistic to FCS 
exosomes with respect to CSR, in other words, CH12 exosomes are potentially 
inhibitory for CSR. 
 
 
6.2.3 Complementation with endogenous and exogenous exosomes rescue 
CSR 
To validate the role FCS and CH12 exosomes play in CSR regulation, we attempted 
to rescue the CSR efficiency decrease caused by absence of FCS and CH12 
exosomes via complementing purified FCS and CH12 exosomes to our previous 
experimental conditions. Exosomes from FCS, inactivated CH12 and activated CH12 
were collected as stated in the methods section above. 
 
Naïve CH12 were activated to undergo CSR by cytokine stimulation in exosome-free 
cell culture medium, with mock, GW4869 treatment and no treatment as control. 
Each condition was complemented with FCS, inactivated CH12, activated CH12 
derived exosomes and no exosomes as control respectively. After 48 hours post 
cytokine stimulation, FCS exosomes complemented conditions including no 
treatment and GW4869 treatment have recovered CSR efficiency lost up to 92% 
compared to CSR in FCS exosome-containing cell culture medium which has been 
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set as 100% (Fig. 3E). 
 
Interestingly, exosomes derived from inactivated and activated CH12 showed 
contrasting effects on CSR. All inactivated CH12 exosomes complemented 
conditions exhibited a significant reduction in CSR compared to control which is 
corresponding to our previous observation. Whilst in activated CH12 exosomes 
complemented with GW4869 treatment condition, the impaired CSR efficiency was 
rescued and surpassed the no treatment control, but not the FCS exosome-
containing cell culture medium condition (Fig. 3E). This indicates exosomes derived 
from activated CH12 have opposite effect to exosomes derived from inactivated 
CH12. In other words, activated CH12 exosomes itself might have a role in positively 
promoting CSR in other neighbour naïve B cells. Indeed, more work needs to be 
done in order to reveal the molecular constituents within these exosomes and to 
understand the interplay between these exosomes and recipient cells in order to 
establish the underlying mechanism of this observed effect. 
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Fig. 3 CSR efficiency is regulated by exogenous (fetal calf serum FCS-derived) and endogenous 
exosomes. A) TEM of isolated exosomes from mock treated CH12. Red arrows indicate presence of 
exosomes. B) TEM of isolated exosomes from GW4869 treated CH12, no detectable exosomes 
presented. C) Determination of half maximal inhibitory concentration IC50 of GW4869 by flow 
cytometry, x-axis: GW4869 concentration, y-axis: % of live cells (n=3 per group). Data shown the 
mean of the three independent experiments. ± Standard deviation is shown; *p<0.05. D) CH12 CSR 
from IgM to IgA with the absence of exogenous exosomes (black), absence of endogenous exosomes 
(dark blue) and absence of both exogenous and endogenous exosomes (red). (n=3 per group), ± 
Standard deviation is shown; *p<0.05. E) CH12 CSR with complement of FCS-derived (yellow), 
inactivated CH12-derived (green) and activated CH12-derived (pink) under the depletion of 
endogenous and exogenous exosomes, presenting data from only 1 independent experiment which 
has to be repeated for validation. 
 
6.3.1 Characterization of exosomal RNA cargo in CH12 cell line 
Apart from surface proteins, a number of studies have shown that cargo within 
exosomes, especially RNA, play a vital role in intercellular communication via 
targeted gene regulation. From our previous observations, where exosomes derived 
from different maturation state in CH12 possess contradictory effects towards CSR, 
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we attempted to isolate and characterize exosomal RNA from both inactivated and 
activated CH12, in order to unveil their molecular constituents to gain a better 
understanding of the underlying mechanism. 
 
We compared a commercial total exosomal RNA kit combining both organic 
extraction and spin column with glass fibre filter to TRI reagent RNA extraction 
method to ensure the quality and quantity of RNA were measurable and comparable 
for downstream experiments. Surprisingly, the RNA quality and quantity from the 2 
methods were significantly different. In the commercial kit method, the RNA yield 
was about 4 ng/µL and the majority of the nucleic acid sized around 150 nt, without 
the presence of 18s or 28s rRNA (Fig. 4A, 4B). In the TRI reagent method, the RNA 
yield was around 100ng/µL and the nucleic acids were enriched in multiple size 
regions ranging from 100 nt to 4000 nt with the presence of 18s and 28s rRNA (Fig. 
4A, 4B) which correspond to (3) findings in lymphoblastoid cell lines. This suggested 
that glass fibre filter column-based kits tend to select for small RNAs whilst TRI 
reagent method is better in capturing total RNA from exosomes. Based on the yield 
and the RNA profile compared to published data, we selected TRI reagent-based 
method to extract exosomal RNA from all of our samples. 
 
6.3.2 Selective packaging of RNA cargo during CSR in exosomes 
To understand the molecular constituents contributing to either promotion or 
inhibition of CSR via exosomal pathway, we extracted RNA from inactivated and 
activated CH12 and their exosomal RNA. Tapestation analyses that measures 
cellular RNA quantity and quality suggested that no significant changes in RNA 
species exist before or after CSR within B cells but the exosomal RNA profile 
appeared quite different from the parental cells. In cellular RNA, a single clear peak 
detected at around 100 nt which might represent small non-coding RNAs plus 18s 
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and 28s rRNA peaks (Fig. 4C). Exosomal RNA species, on the other hand, exhibited 
multiple clear peaks ranging from 100 nt to 600 nt which possibly represent small 
non-coding RNAs together with 18s, 28s rRNA peaks and 2 peaks around 1200 nt 
and 3000 nt which might represent long non-coding RNA (Fig. 4D). During CSR, the 
amount of each RNA species found in exosomes were significantly transformed. 
Before CSR, the amount of small non-coding RNA sized from was enriched 
compared to post CSR; whilst the amount of rRNA and long non-coding RNA post 
CSR was significantly increased (Fig. 4D). This suggests that CH12 selectively 
package the exosomal RNA cargo during CSR. Indeed, it is yet to be confirmed 
whether such exosomal RNA transformation is the cause of CSR promotion via 
exosomal pathway but it is an interesting prospect given the role ncRNA has been 
shown to play in CSR efficiency (18) (20).  
 
 
Fig. 4 Characterization of CH12 exosomal RNA cargo. A) Electropherogram showing CH12 exosomal 
RNA isolated with commercial column kits (grey filled) and with TRI reagent (black open). B) Virtual 
gel image and RIN score corresponding to (A). C) Electropherogram showing CH12 cellular total 
RNA, ±CSR after 48 hours, blue, -CSR; red, +CSR (n=3 per group). D) Electropherogram showing 
CH12 exosomal total RNA, ±CSR after 48 hours, blue, -CSR; red, +CSR (n=3 per group). 
 
 
6.3.3 Testing enrichment of certain ncRNA during CSR activation 
To further understand the role of exosome in CSR by the means of enriching and 
shuttling certain non-coding RNA between B cells, we attempted to quantify the 
expression variance of CH12 CSR related genes including activation-induced 
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cytidine deaminase (AID), switch region alpha (Sα), switch region mu (Sµ) and Sµ 
lariat, in cells and exosomes by RT-qPCR. Briefly, total RNA isolated from CH12 cells 
and exosomes, ± stimulation for CSR. Isolated RNA was reverse transcribed to 
cDNA and subjected to qPCR for the expression of the genes listed above relative to 
β-actin. 
 
From our preliminary qPCR results from cellular RNA, the concentration of Sα in 
switched CH12 was 20% more compared to unswitched CH12, despite the increase 
was expected to be around 10 times instead. Interestingly, concentration of Sµ lariat 
in switched in switched CH12 was double compared to unswitched CH12, indicating 
Sµ lariat was enriched during CSR in cells. Concentration of both Sµ and AID in 
switched CH12 were far less than unswitched CH12 which didn’t correspond to 
published data that both genes express at a constant level before and after CSR (Fig 
5A). 
 
 
Fig. 5 Testing enrichment of certain ncRNA during CSR activation by RT-qPCR. A) Expression of AID, 
Sα, Sµ and Sµ lariat in CH12 cells, ± stimulation for CSR, normalized to β-actin. Data represents the 
average of 3 independent experiments. ± SD. B) Expression of AID, Sα, Sµ and Sµ lariat in CH12 
exosomes, ± stimulation for CSR, normalized to β-actin. Data represents the average of 3 
independent experiments. ± SD. 
Whilst from the qPCR results in exosomal RNA, the concentration of all 4 CSR 
related transcripts from switched CH12 derived exosomes were decreased 
compared to unswitched CH12 derived exosomes. Concentration of Sα in switched 
CH12 derived exosomes were around 60% less than that in unswitched CH12 
derived exosomes. Concentrations of Sµ lariat and Sµ in switched CH12 derived 
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exosomes were around 80% less than that in unswitched CH12 derived exosomes. 
AID concentration in switched CH12 derived exosomes was 1000 times less than 
that in unswitched CH12 derived exosomes (Fig 5B). 
 
6.3.4 Characterization of exosomal RNA cargo in primary B cells 
In addition to studying CH12 cell lines, we also investigated the exosomal RNA cargo 
in primary B cells for comparison and confirmation. Since cell lines are prone to 
genetic and phenotypic drift as mutation occurs and results generated could be 
varied from parental origin to certain extent, primary splenic B cells from wild type 
C57BL/6 were chosen to eliminate the possibility of cell lines-specific phenotypes in 
CH12. However, there are several intrinsic limitations of using primary B cells in our 
experimental design. Unlike CH12 which is immortalized and able to proliferate 
without cytokine stimulation, primary B cells has to be stimulated by T cell derived 
cytokines to survive and proliferate ex vivo, followed by CSR from IgM to the IgG1 or 
IgG3, respectively. In contrast to CH12 that are able to grow in 
unstimulated/unswitched state, primary B cells has to be stimulated by cytokines (i.e. 
IL-4 and LPS) and undergo CSR in order to survive and proliferate once isolated 
from the spleen, otherwise more than 99% of the cell population die within overnight 
after isolation from spleens (21). This created a technical problem for our analysis of 
primary B cells due to the lack of legitimate unstimulated primary B cells and 
exosomes derived from them to use as control. Therefore, unlike with CH12, we 
isolated exosomes from primary B cells every 24 hours in order to thoroughly trace 
quality and quantity of the exosomal RNA as their parental cells were proliferating 
and underwent CSR. In addition, on our hands, the amount of exosomal RNA 
isolated from primary B cells derived exosomes were 10 times less than that in CH12 
derived exosomes which made downstream quantitation and qualification even more 
challenging. 
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Interestingly, primary B cells were able to grow but remain unswitched for 36 hours 
after isolation from spleen just by incubating them with exosomes derived from 
switched CH12 without any cytokine stimulation. The live cell percentage in this 
condition was about 30% less than that in cytokine stimulated condition (Fig 6A). 
This phenotype hasn’t been reported previously and it suggested that the certain 
exosomal cargo from switched B cells were aiding cell survival akin to T cell derived 
cytokines. In addition, the efficiency of primary B cell CSR from IgM to IgG1 was 
about 25% 72 hours after cytokine stimulation which was corresponding to published 
data (22). Surprisingly, in our experimental set up, we managed to increase the CSR 
efficiency of primary B cells up to 65% 72 hours after cytokine stimulation (Fig 6B & 
6C). It seemed that the procedure of isolating exosomes from the cell culture every 
24 hours and replacing with fresh media could enhance the CSR efficiency in 
primary B cells. This indicates certain exosomal cargo from stimulated primary B 
cells were antagonistic to CSR however this needs further confirmations and an in-
depth analysis of the potential mechanisms for such possible phenotype. 
 
Primary B cells exosomal RNA were isolated 24 and 72 hours after stimulation for 
CSR using commercial column-based kit. Since there was a lack of unstimulated 
primary B cell derived exosomes control as stated previously, the 24 hours timepoint 
was our earliest control we could use to isolate an adequate amount exosomal RNA 
for downstream analysis. Therefore, we chose to isolate exosomal RNA at 24 hours 
to represent the unstimulated control. Indeed, this wasn’t the most ideal control and 
could possibly vary from the real unstimulated control. Isolated exosomal RNA were 
subjected to Tapestation analysis (Fig 6D) as done previously. Exosomal RNA 
isolated 24 hours were enriched in the size range of 100 to 150 nt, which might be 
small ncRNA and such enrichment was absence 72 hours after stimulation. 
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Interestingly, exosomal RNA sized 750 to 1200 nt were slightly enriched in the 72 
hours sample compared to 24 hours sample. This indicated a selective RNA cargo 
packaging during CSR in primary B cells like CH12. As mentioned before, the 
commercial column-based kit seemed to select for small RNA rather than total RNA 
like TRI reagent isolation. Thus, the true landscape of the exosomal RNA profile and 
enrichment changes in primary B cells is yet to be confirmed. Furthermore, in depth 
analysis of exosomal RNA, such as RT-qPCR and RNA-seq are needed to be done 
to reveal the molecular network involved and to explain CSR efficiency enhancement 
by the means of removing exosomes in cell culture every 24 hours. 
 
 
 
Fig. 6 Characterization of exosomal RNA cargo in primary B cells. A) Cytogram showing forward 
scatter and side scatter, primary B cells without cytokine stimulation in grey, primary B cells incubated 
with exosomes and without cytokine stimulation in orange and primary B cells with cytokine 
stimulation in blue, live cell population in oval gate. B) Efficiency of primary B cell (n=3 per group) 
CSR from IgM to IgG1 (in oval gate), 72 hours after cytokine stimulation without daily exosome 
removal. C) Efficiency of primary B cell (n=3 per group) CSR from IgM to IgG1 (in oval gate), 72 hours 
after cytokine stimulation with daily exosome removal. D) Electropherogram showing primary B cell 
exosomal RNA, 24 hours after stimulation in red and 72 hours after stimulation in blue. 
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7 Discussion 
 
Emerging evidences revealed exosomes as a novel player in intercellular 
communication via various mechanisms such as surface peptide interaction and 
targeted gene regulation. The full potential of exosomes involving in cell to cell 
communication is yet to be discovered due to their high mobility throughout the 
human body and remarkably stable structure for preservation and delivery of 
peptides and nucleic acids between distant cells. Excessive studies have shown 
exosomes are involved in regulating immune response, especially between T cell 
and dendritic cells. Apart from direct peptide or antigen presentation, certain 
pathways are rather complex which involve multi-step and multi intermediate 
molecules. Understanding the fundamental mechanism would certainly aid to answer 
various unsolved queries in immunity responses. In this thesis, we attempted to 
investigate the exosome-mediated B cell to B cell communication pathway through 
series of experiments, from characterization of B cell exosomes, role of B cell 
exosomes in CSR to finally looking into the molecular constituents in B cell 
exosomes derived from different stage of maturation. Regarding to exosome 
detection approaches, TEM is still the more accurate method to measure the sizes of 
exosomes as well as surface marker detection using immunogold labelling compared 
to nanoparticle tracking analysis (23). However, TEM for detecting multiple types of 
surface marker simultaneously in a clinical application is rather tedious and labor 
intensives. Also, TEM lacks of the ability of exosomes quantification which is vital for 
researchers and clinical practitioners in the field to generate quantitative conclusions 
in experiments. Compared to TEM, flow cytometry-based method is relatively more 
robust and efficient. Nevertheless, current flow cytometry-based method for 
analyzing exosomes require experienced users and dedicated flow cytometers to 
produce reliable results. In order to simplify the complex flow cytometer 
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customization process and to popularize this method across most available flow 
cytometers, part of our future work will be optimize the CellTrace-based and 
immune-beads based flow cytometry method with respect to accuracy and 
sensitivity. Aside from TEM and flow cytometry, the recent emergence of different 
types of super-resolution microscopy has been employed in exosome study. Briefly, 
super-resolution microscopy applied in exosome study is a coupling of conventional 
optical microscopy and novel optical imaging techniques such as photo-switchable 
fluorophores in order to overcome the limited resolution of nano-sized particles like 
exosomes caused by the diffraction limit of light. Super-resolution microscopy also 
remains the advantages of conventional optical microscopy such as non-invasive 
imaging and high biochemical specificity. Such breakthrough of resolution limit of 
optical microscopy has the potential of being an evolutionary tool to study exosomes 
between TEM and flow cytometry. Firstly, the sample preparation time required for 
imaging using super-resolution microscopy is significantly less compared to TEM. 
Secondly, because of the feasibility of colocalization of multiple markers on single 
exosome particles in super-resolution microscopy, it is possible to gather more 
comprehensive information about exosome surface molecules compared to TEM 
(which only allows labelling 1 marker at a time by immune-gold). Furthermore, unlike 
flow cytometry, optical microscopy-based method is in fact producing images of 
inputted samples which can eliminate the possibility of false study target in flow 
cytometry due to improper setup of flow cytometer for studying exosomes. In our 
study, the reliable labelling and imaging of exosomes offered by super-resolution 
microscopy hold great potential in the investigation of B cell exosomal surface Ig profile and the 
interaction between exosomes and parental cells. 
 
Interestingly, in vitro, exogenous exosomes from FCS seemed to be essential for 
efficient CSR and we are the first to report this information up to our knowledge. As 
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expected, the underlying mechanism is yet to be established regarding to the 
intercellular molecular interactions. Additionally, exosomes derived from inactivated 
CH12 appeared to be inhibiting CSR whilst activated CH12 exosomes showed an 
enhancing effect in CSR and this experiment has to be repeated to confirm 
significance of the data. Nonetheless, the exosome inhibition effect by GW4869 
treatment is yet to be validated by TEM or flow cytometry in order to confirm the 
phenotype mentioned above is actually due to depletion of exosomes rather than 
drug toxicity. Several important information was gathered from the preliminary 
analysis of exosomal RNA cargo using the Tapestation platform. Different exosomal 
RNA extraction methods could lead to contrastive conclusions, for instance, 
commercial column-based kit tended to select for small exosomal RNA and TRI 
reagent method has a higher coverage of total exosomal RNA. The choice of 
exosomal RNA extraction approach is certainly vital in order to capture the type of 
RNA desired for future studies. Also, the difference in exosomal RNA profile between 
unswitched and switched CH12 clearly indicated a selective exosomal RNA cargo 
packaging mechanism during CSR. RT-qPCR were then used to test whether certain 
CSR-related transcripts were involved in such selective exosomal RNA cargo 
packaging during CSR. 
 
Unfortunately, and possibly due to technical limitations and time constraints at the 
end of my thesis work, we weren’t able to draw confident conclusions. Thus, RT-
qPCR with more housekeeping gene controls has to be done in the future in order to 
validate the expression of CSR-related transcripts and better understand the 
underlying mechanism of the selective exosomal RNA cargo packaging. Apart from 
CH12, several optimizations are needed for the validate experiments with primary B 
cells exosomal RNA. To obtain a legitimate unstimulated/unswitched control, one 
possible approach is to purify exosomes directly from mouse blood by serial 
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ultracentrifugation and to capture splenic B cell derived exosomes by magnetic 
separation using magnetic bead coupled with splenic B cell-specific primary 
antibodies. Also, TRI reagent method can be applied to extract primary B cell 
exosomal RNA in order to obtain total RNA for downstream experiments. Later work 
such as deep sequencing of cellular and exosomal RNA from both inactivated and 
activated CH12 and primary B cells is essential for us to thoroughly understand the 
underlying mechanism such as the selective packaging of exosomal RNA during 
CSR as well as identification of differentially expressed genes which are responsible 
of the enhancement or suppression in CSR. The succeeding task should be 
originated from the genes identified in deep sequencing and,by means of gene 
knockout or overexpression, we hope to gain better knowledge in immune response 
regulation and immune cells development via exosomal pathway, especially within B 
cells. Ultimately, through optimizing the whole cascade of experiments we applied in 
this thesis, we expect to turn this methodology into an alternative platform as a non-
invasive diagnostic tool for cancer and autoimmune diseases as well as an 
exosome-based therapeutic approach. 
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